The robust indigenous IgG ELISA test for antibody detection developed by ICMR-NIV, Pune will play a critical role in surveillance for COVID-19": Dr Harsh Vardhan

Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV) at Pune has developed and validated the indigenous IgG ELISA test “COVID KAVACH ELISA” for antibody detection for COVID-19.

COVID-19 pandemic has spread across 214 countries with a total of 38,55,788 confirmed cases and 2,65,862 deaths. Most countries in the world are struggling to contain the pandemic using possible interventions. There is an augmented demand of various types of diagnostic tests by countries across the globe. Most of the diagnostic material for COVID-19 is imported into India from other countries. Therefore, Indian scientists are tirelessly engaged in developing indigenous diagnostics for SARS-CoV-2, the causative agent of COVID-19.

ICMR-National Institute of Virology (NIV), Pune is the apex laboratory of the country with state-of-art infrastructure and expertise for research in virology. NIV’s competent scientific team successfully isolated the SARS-CoV-2 virus from laboratory confirmed patients in India. This in turn has paved the way for development of indigenous diagnostics for SARS-CoV-2. 

While real time RT-PCR is the frontline test for clinical diagnosis of SARS-CoV-2, robust antibody tests are critical for surveillance to understand the proportion of population exposed to infection.

The scientists at ICMR-NIV, Pune have enthusiastically worked to develop and validate the completely indigenous IgG ELISA test for antibody detection for SARS-CoV-2. The test was validated at two sites in Mumbai and has been found to have high sensitivity and specificity. In addition, the test will have the advantage of testing 90 samples together in a single run of 2.5 hours. Moreover, ELISA based testing is easily possible even at district level as the ELISA kit has inactivated virus. There are also minimal biosafety and bio-security requirements as compared to the real-time RT-PCR test. The test has an advantage of having much higher sensitivity and specificity as compared to the several rapid test kits which have recently flooded the Indian market.

Speaking on the occasion, Dr Harsh Vardhan said, “The robust indigenous IgG ELISA test for antibody detection developed by ICMR-NIV, Pune will play a critical role in surveillance of proportion of population exposed to SARS-CoV-2 Coronavirus infection.”

ICMR has partnered with Zydus Cadila for mass scale production of the ELISA test kits. After development at ICMR-NIV, Pune, technology has been transferred for mass scale production to Zydus Cadila, which is an innovation driven global healthcare company. Zydus has proactively taken up the challenge to expedite the approvals and commercial production of the ELISA test kits so that they can be made available for use at the earliest. The test is named as “COVID KAVACH ELISA”. This is a perfect example of “Make in India” in record time.

PE firm Vista Equity to invest Rs 11,367 crore in Jio Platforms

Private equity firm Vista Equity Partners will invest Rs 11,367 crore (US$ 1.61 billion) in Jio Platforms for a 2.32 per cent stake. This is Jio Platforms' third deal after Facebook and Silver Lake’s share acquisition plans over the last two weeks.

“This investment values Jio Platforms at an equity value of Rs 4.91 lakh crore (US$ 69.66 billion) and an enterprise value of Rs 5.16 lakh crore (US$ 73.22 billion)," said Reliance Industries.

"We believe in the potential of the Digital Society that Jio is building for India. Mukesh’s vision as a global pioneer, alongside Jio’s world-class leadership team, have built a platform to scale anda advance the data revolution it started. We are thrilled to join Jio Platforms to deliver exponential growth in connectivity across India, providing modern consumer, small business and enterprises softwareto fuel the future of one of the world’s fastest growing digital economies," said Mr Robert F. Smith, Founder, Chairman and CEO of Vista.

The net combined value of Jio Platform reached Rs 60,596 crore (US$ 8.60 billion) for the unit of Reliance Industries after the investment from Vista equity. The business comprises mainly of its telecom under Reliance Jio Infocomm, which is the largest in the country with over 388 million subscribers.

Vista will be the largest investor in Jio Platforms after RIL and Facebook. On April 22, 2020, Facebook announced that it would invest US$ 5.7 billion in Jio Platforms for a 9.99 per cent stake. Then on May 4, US private equity firm Silver Lake announced an investment of Rs 5,655.75 crore (US$ 802.35 million) in Jio Platforms for a 1.15 per cent stake.

Vista has more than US$ 57 billion in cumulative capital commitments and its global network of companies collectively represent the fifth largest enterprise software company in the world. Presently, Vista portfolio companies have a significant presence in India with over 13,000 employees.

The world's largest tech investor, Silver Lake Partners announced an investment of Rs 5,655.75 crore (US$ 802.35 million) to buy a 1.15 per cent stake in billionaire Mr Mukesh Ambani's digital unit that houses India's youngest but biggest telecom firm.

This investment by Silver Lake was at a 12.5 per cent premium to the Facebook's US$ 5.7 billion investment for a 9.99 per cent stake in the firm.

Earlier, 9.99 per cent stake in Jio Platforms were brought by Facebook for US$ 5.7 billion at an enterprise value of Rs 4.62 lakh crore (US$ 65.54 billion).

The financial advisor for the completion of deal was Morgan Stanley.

Dr Harsh Vardhan launches the 'Sanjivani' App and inter-disciplinary studies involving AYUSH interventions for COVID 19

Dr Harsh Vardhan, Union Health & Family Welfare Minister launched the ‘AYUSH Sanjivani’ App  and two AYUSH based studies related to COVID-19 situation, here today, in the presence of Shri Shripad Yesso Naik, MoS (I/c), AYUSH who participated through Video Conferencing from Goa.

Highlighting the importance of harnessing technology for COVID-19 response, the Union Health Minister said “The ‘AYUSH Sanjivani ’ mobile app, which has been launched today, will help to generate data on acceptance and usage of AYUSH advocacies and measures among the population and its impact in prevention of COVID 19. It is developed by Ministry of AYUSH and MEITY and shall reach out to a target of 50 lakh people.”

Dr Harsh Vardhan stated that COVID-19 mangement has provided a potent platform for alliance between MoHFW, MoAYUSH and technology organisations such as CSIR, ICMR, and UGC to not only develop AYUSH interventions and solutions, but also help in promoting AYUSH knowledge for the larger good of the global community. These organisations are joinging hands today and are being supported and guided by ICMR and DCGI in propagating the wholesomeness and holistic health benefits of the age-old traditional medicinal knolwedge of Ayurveda, he added.

In addition to the App, Dr Harsh Vardhan also launched two more scientific studies. One is the collaborative clinical research study on Ayurveda interventions as prophylaxis and as an add-on to standard care to COVID-19, which shall be a joint initiative of Ministry of AYUSH, Ministry of Health and Family Welfare (MoHFW) and the Ministry of Science & Technology through Council of Scientific & Industrial Research (CSIR) with technical support of ICMR. The Interdisciplinary Ayush R&D Task Force headed by Dr Bhushan Patvardhan, Vice Chairman, University Grant Commission (UGC), has formulated and designed clinical research protocols for prophylactic studies and add-on interventions in COVID-19 positive cases through thorough review and consultative process of experts of high repute from different organisations across the country for studying four different interventions viz. Ashwagandha, Yashtimadhu, Guduchi +Pippali and a poly herbal formulation (AYUSH-64). This includes the following two areas:

 

1. Ashwagandha for the Prophylaxis Against SARS-COV-2 in subjects with increased risk during the COVID-19 Pandemic: A comparison with Hydroxychloroquine in the health care providers, and
2. Effectiveness of Ayurveda Formulation as an adjunct to ‘Standard of Care’ for the Treatment of Mild to Moderate COVID-19: A Randomized, Open Label, Parallel Efficacy, Active Control, Multi-Centre Exploratory Drug Trial.

 

Dr Harsh Vardhan also launched the population based interventional studies on impact of AYUSH based prophylactic interventions for prevention of COVID-19 infection in high risk population. The core objectives comprise of assessment of preventive potential of AYUSH interventions for COVID-19 and to assess the improvement in quality of life in high risk population. The study will be carried out through four Research Councils under Ministry of AYUSH and National Institutes in 25 states across the country and several State Governments covering approximately 5 lakh population. The outcome of the study is expected to pave a new horizon in understanding the preventive potential of AYUSH interventions during pandemics like COVID-19 through scientific evidence.

Elaborating on the import of these studies, Dr Harsh Vardhan stated that these studies shall re-establish the importance of AYUSH pathies with the help of rigour of CSIR, ICMR and DCGI. “This is truly a momentous day. The technology alliance provides valuable opportunity for such knowledge-based solutions to continue to benefit us even after the COVID-19 pandemic has passed, by possible integration of AYUSH in the mainstream scientific efforts”, he added. Let us also understand that the modern pathies of medicine and science are not in competition with those of AYUSH, but they complement and strengthen each other in intrinsic ways, Dr Harsh Vardhan stated. Under the leadership of our beloved Prime Minister, AYUSH advisories for enhancing immunity during COVID-19 pandemic have been acknowledged the world over, he said.

Shri Rajesh Bhushan, OSD/Secretary (HFW), Shri Vaidya Rajesh Kotecha, Secretary, AYUSH, Dr Shekhar Mande, Director General, Council of Scientific & Industrial Research, Dr V. G. Somani, Drugs Controller General of India, and other senior officers of MoHFW and AYUSH were also present at the launch event.

465 flights operated under Lifeline Udan to deliver critical medical supplies across the country

465 flights have been operated under Lifeline Udan by Air India, Alliance Air, IAF and private carriers. 278 of these flights have been operated by Air India and Alliance Air. Cargo transported till date is around 835.94 tons.  Aerial distance covered by Lifeline Udan flights till date is over 4,51,038 km. ‘Lifeline Udan’ flights are being operated by MoCA to transport essential medical cargo to all parts of the country including remote and hilly areas to support India’s war against COVID-19.

Helicopter services including Pawan Hans Ltd have been operating in J&K, Ladakh, Islands and North East region transporting critical medical cargo and patients. Pawan Hans till 5th May 2020 have carried 2.27 tons of cargo covering 7,729 kms.  Special focus has been on the North East Region, island territories and the hill states. Air India and IAF collaborated primarily for J&K, Ladakh, North-East and other island regions.

Domestic Cargo Operators SpiceJet, Blue Dart, Indigo and Vistara are operating cargo flights on a commercial basis. Spicejet operated 819 cargo flights covering 13,83,854 km and carrying 5,946 tons of cargo. Out of these, 294 were international cargo flights. Blue Dart operated 278 cargo flights covering 3,09,272 km and carrying 4,683 tons of cargo. Out of these, 14 were international cargo flights. Indigo has operated 95 cargo flights covering 1,59,158 km and carrying around 470 tons of cargo and including 38 international flights.  This also includes medical supplies carried free of cost for the government.

Vistara has operated 23 cargo flights covering 32,321 km and carrying around 150 tons of cargo. 

A cargo air-bridge was established with East Asia for transportation of pharmaceuticals, medical equipment and COVID-19 relief material. The quantity of medical cargo brought in by Air India is 972 tons. Blue Dart has uplifted medical supplies of around 114 tons from Guangzhou and Shanghai and 24 tons from Hong Kong, starting 14th April up to 5th May 2020. Spicejet has also uplifted 204 tons of medical supplies from Shanghai and Guangzhou up to 5th May 2020 and 16 tons medical supplies from Hong Kong and Singapore up to 5th May 2020.

Prime Minister Shri Narendra Modi addressed the virtual 'Vesak Global Celebrations' on Buddha Purnima today

Prime Minister Shri Narendra Modi addressed the virtual Vesak Global Celebrations on Buddha Purnima today. Minister of State for Culture(I/C) and Minister of State for Tourism(I/C), Shri Prahlad Singh Patel and Minister of State for Youth Affairs & Sports(I/C) and Minister of State for Minority Affairs, Shri Kiren Rijiju also participated in the event held virtually.

Prime Minister Shri Narendra Modi in his keynote said that the life, teachings and message of Lord Buddha have continued to enrich the lives of people across the globe. His message is not limited to any one circumstance, or to any one subject. Time changed, the situation changed, the functioning of society changed, but the message of Lord Buddha has been continuously flowing in our lives.  Buddha is not just a name, but also a sacred thought, a thought that beats in every human heart and guides humanity.

Prime Minister further said that Friends, each and every word, each and every discourse of Lord Buddha reinforce India's commitment to serve humanity. Buddha symbolizes both the Enlightenment of India and the Self-Realization of India. With this self-realization, India is and will continue to work for the benefit of entire humanity, the whole world. India's progress will always be helpful in the progress of the world. 

Kindly click the link below for full speech of Shri Narendra Modi

•  

Speaking on the occasion, Minister of State for Culture(I/C) and Minister of State for Tourism (I/C) Shri Prahlad Singh Patel congratulated  everyone on the Buddha Purnima and expressed his gratitude towards Prime Minister Shri Narendra Modi ji who had taken the initiative to observe Buddha Purnima as national celebration in 2015. Shri Patel said that Lord Buddha shows us the power of love and nonviolence. Lord Buddha teaches the whole word that non-violence is the language of knowledge. He said that Lord Buddha teaches the power of love to the world. Shri Patel also shared examples of Lord Buddha’s preaching during his address.

Minister of State for Youth Affairs & Sports(I/C) and Minister of State for Minority Affairs, Shri KirenRijiju said that  "I am feeling great that people from all over the word gathered virtually just like a family to celebrate the Buddha Purnima in the time of Covid-19 . I believe this is the best example of VasudhaivaKutumbakam, which means the world is one family."

Ministry of Culture, Government of India in collaboration with the International Buddhist Confederation (IBC), a global Buddhist umbrella organised the Virtual Prayer Event with the participation of  heads of  Buddhist Sanghas from around the world. Buddha Purnima celebrations are being held through a virtual congregation owing to the impact of the COVID-19 Pandemic across the globe. It is also being dedicated as Global Prayer Week  in honour of the Victims and the frontline warriors of COVID-19.

Prayer ceremonies on the occasion were streamed live from the Mahabodhi Temple, Bodhgaya , Mulgandha Kuti Vihara, Sarnath, India, Parinirvana Stupa, Kushinagar ,India ; Sacred Garden Lumbini, Nepal; Pirith Chanting from Ruwanweli Maha Seya in the sacred and historic Anuradhapura stupa premises, Sri Lanka;  Boudhanath, Swayambhu, Namo Stupas, Nepal apart from other popular Buddhist sites.

The program was live streamed on FB live, YouTube from IBC social media handles as well as on Mandala mobile app.

It was viewed by large audiences in India ,Australia, Bangladesh, Bhutan, Cambodia, Czech Republic, France, Germany, Indonesia, Japan, S. Korea,  Myanmar, Mongolia, Malaysia, Nepal, Russia, Sri Lanka, Singapore, Taiwan, Vietnam among others. 

Vesak- Buddha Poornima, is considered the Triple Blessed Day as it celebrates Tathagata Gautam Buddha's Birth, Enlightenment and Maha Parnirvana.

Pradhan Mantri Garib Kalyan Package: Progress so far; Around 39 crore poor people received financial assistance of Rs 34,800 crore under the PMGKP

Using the digital payment infrastructure, around 39 crore poor people received financial assistance of Rs 34,800 crore (US$ 4.94 billion) under the Pradhan Mantri Garib Kalyan Package (PMGKP) as on 5th May, 2020, announced by Union Finance Minister Smt Nirmala Sitharaman on 26th March, 2020 to protect them from the impact of the lockdown due to COVID 19.

As part of the PMGKP, the Government announced free food grains and cash payment to women and poor senior citizens and farmers. The swift implementation of the package is being continuously monitored by Central and State governments. Finance Ministry, the concerned Ministries, Cabinet Secretariat and PMO are leaving no stone unturned to ensure that the relief measures reach the needy swiftly and in line with the intent of the lock down.

Fintech and digital technology have been employed for swift and efficient transfer to the beneficiary. Direct Benefit Transfer (DBT), i.e. transfer that ensures that the amount is directly credited into the account of the beneficiary, eliminates leakage and improves efficiency has been employed. This has also ensured credit to the beneficiary’s account without the need for the beneficiary to physically go to the branch.

The progress achieved so far, under various components of PMGKP is as follows:

• Rs 16,394 crore (US$ 2.33 billion) front loaded towards payment of the first instalment of PM-KISAN to 8.19 crore beneficiaries.
• Rs 10,025 crore (US$ 1.42 billion) credited to 20.05 crore (98.33 per cent) women Jan Dhan account holders as first instalment. The number of women PMJDY accounts holders whose accounts have been debited by customer induced transaction is 8.72 crore (44 per cent). Rs 2,785 crore (US$ 395.09 million) credited to 5.57 crore women Jan Dhan account holders with second instalment as on 5 May, 2020.
• Rs 1,405 crore (US$ 199.32 million) disbursed to about 2.82 crore old age persons, widows and disabled persons. Benefits transferred to all 2.812 crore beneficiaries.
• 2.20 crore Building & Construction Workers received financial support amounting to Rs 3,492.57 crore (US$ 495.97 million).
• So far 67.65 lakh MT of food grains have been lifted by 36 States/UTs for April. 30.16 LMT of foodgrains have been distributed, covering 60.33 crore beneficiaries by 36 States/UTs for April 2020. 6.19 LMT of food grains have been distributed, covering 12.39 crore beneficiaries by 22 States/UTs for May 2020. 2.42 LMT of Pulses have also been dispatched to various states/UTs. Pulses have been distributed so far to 5.21 crore household beneficiaries out of 19.4 crore such beneficiaries.
• Total 5.09 crore Pradhan Mantri Ujjwala Yojana (PMUY) cylinders have been booked under this scheme so far and 4.82 crore PMUY free cylinders already delivered to beneficiaries.
• 9.6 Lakh members of Employees’ Provident Fund Organisation (EPFO) has taken benefit of online withdrawal of non-refundable advance from EPFO account amounting to 2,985 crore. 24 per cent EPF contribution transferred to 44.97 Lakh employees account amounting to Rs 698 crore (US$ 99.02 million).
• Increased rate of MGNREGA has been notified w.e.f 01-04-2020. In the current financial year, 5.97 crore person’s man-days of work generated. Further, Rs 21,032 crore (US$ 2.98 billion) released to States to liquidate pending dues of both wage and material.

• Insurance Scheme for Health workers in Government Hospitals and Health Care Centres has been operationalised by New India Assurance covering 22.12 lakh health workers.

Pradhan Mantri Garib Kalyan Package

Total Direct Benefit Transfer till 05/05/2020

Scheme	Number of Beneficiaries	Amount (Rs)	Amount
Support to PMJDY women account holders	1st Ins - 20.05 crore (98.3 per cent)	1st Ins - 10,025 crore	1st Ins - US$ 1.42 billion
	2nd Ins - 5.57 crore	2nd Ins – 2,785 crore	2nd Ins – US$ 359.09 million
Support to NSAP (Aged widows, Divyang, Senior citizen)	2.82 crore (100 per cent)	1,405 crore	US$ 199.32 million
Front-loaded payments to farmers under PM-KISAN	8.19 crore	16,394 crore	US$ 2.33 billion
Support to Building & Other Construction workers	2.20 crore	3493 crore	US$ 495.97 million
24 per cent contribution to EPFO	45 crore	698 crore	US$ 99.02 million
TOTAL	39.28 crore	34,800 crore	US$ 4.94 billion

Flight from Abu Dhabi carrying 177 Indian nationals takes off for Kerala

The first of the two flights from the UAE carrying 177 Indian nationals left for Kerala on Thursday, as India began its biggest ever repatriation exercise to bring back its citizens stranded abroad amidst the international travel lockdown over the coronavirus pandemic.

The Air India Express flight IX452 took off from Abu Dhabi to Kochi, which will be followed by a Dubai-Kozhikode flight of the same airline. Meanwhile, Indian Navy’s INS Jalashwa, has also reached the Maldives to bring back stranded Indian citizens.

Nearly 15,000 Indians stranded overseas are expected to return on special Air India flights from 12 countries over a week, starting Thursday. The government will operate 64 flights until May 13 and use three Navy ships, as part of Phase I of an evacuation plan, named “Vande Bharat Mission”. Of the 64 flights, 15 would be to Kerala, 11 each to Delhi and Tamil Nadu, seven each to Maharashtra and Telangana, and the rest to Gujarat, Punjab, Jammu and Kashmir, Karnataka, and Uttar Prdesh. 

7 hospitalised after gas leak at paper mill in Raigadh

The incident happened last night while workers were cleaning the mill, which had been closed due to the lockdown and was expected to reopen soon.

At least seven workers were hospitalised in Chhattisgarh’s Raigadh district on Thursday after being exposed to poisonous gas while cleaning a paper mill. Of the seven, three were said to be in a serious condition and were being shifted to the capital, Raipur.

The incident happened last night while workers were cleaning the mill, which had been closed due to the lockdown and was expected to reopen soon.

“We were not informed about the incident. We got to know about it from the hospital,” Superintendent of Police (Raigadh) Santosh Singh said. “We are monitoring the situation and will take legal action on the mill owner.”

According to the mill owner Deepak Gupta, three men had gone to clean the paper pulp tank inside the mill, which was to reopen soon. “More men came in to help and all of them had to be hospitalized. Three men are being taken to Raipur, for further treatment,” he said.

Sources said that the men were affected by a carbon-heavy gas, possibly methane, which was trapped in the paper pulp tank, while cleaning.

“Two of the men are being taken to the government hospital in Raipur while one is shifted to a private hospital. All three are critical, while the other four are stable,” a Raigarh district official said.

The incident took place hours before a gas leak from a chemical plant in Andhra Pradesh’s Visakhapatnam killed at least 11 people, including a child. Hundreds were said to have fallen ill due to the leak in Gopalapatnam area, where the plant is located. Close to a 1,000 people have been evacuated from the area.

Thursday’s incident evoked memories of the 1984 Bhopal gas tragedy, when a gas leak at a Union Carbide factory killed thousands. 

Coronavirus India LIVE Updates: Facing flak, Karnataka govt now decides to restart train services for migrants

A day after the Karnataka government’s decision to scrap trains ferrying migrants back home attracted criticism from several quarters, the BS Yeddyurappa-led government on Thursday decided to restart train services for migrant labourers. The state government has written to nodal officers of various states seeking their consent to operate trains to their states from May 8 to 15.

As far as Covid-19 numbers are concerned, the overall tally in the country has touched 52,952, including 1783 deaths. While there are 35902 active cases at present, as many as 15266 patients have recovered so far. The jump in cases came even as the Centre and state governments continued to chalk out lockdown exit strategies after May 17. As many as 64 flights and three Navy ships will be operated until May 13 to bring home nearly 15,000 Indians stranded overseas from Thursday.

Meanwhile, Prime Minister Narendra Modi thanked all those in the frontline of the Covid-19 war, saying their selfless work for others during the pandemic is worthy of praise. He said India is standing firmly with those facing difficult times, both in the country and abroad. “India is standing strong and selflessly in these difficult times with those facing trouble in India or abroad. India’s growth will always be aiding global growth,” he said.

CSIR IGIB and TATA Sons sign an MoU for licensing KNOWHOW related to development of a kit for rapid and accurate diagnosis of COVID-19

CSIR’s constituent lab, Institute of Genomics and Integrative Biology (CSIR-IGIB) and TATA Sons signed a MoU for licensing of KNOWHOW for FNCAS9 Editor Linked Uniform Detection Assay (FELUDA) for rapid diagnosis of COVID-19.

The license shall include transfer of the knowledge for scaling up the KNOWHOW in the form of a kit that can be deployed for COVID-19 testing on ground as early as end of May. A completely indigenous scientific invention, FELUDA for COVID-19 has been designed for mitigating the ongoing COVID-19 situation and cater to mass testing. Its main advantages are its affordability, relative ease of use and non-dependency on expensive Q-PCR machines. CSIR IGIB and TATA Sons will now work together to bring it for widespread use at the earliest.

Commenting on the agreement, Mr Banmali Agrawala, President - Infrastructure and Defence & Aerospace, Tata Sons said, “we are happy to enter into a partnership with Institute of Genomics and Integrative Biology of CSIR (Council of Scientific & Industrial Research) for further development and commercialisation of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) based technology for COVID-19 detection. This innovative CRISPR ‘Feluda’ test uses cutting edge CRISPR technology for detection of genomic sequence of novel coronavirus. It uses a test protocol that is simple to administer and easy to interpret enabling results to be made available to the medical fraternity in relatively lesser time, as compared to other test protocols.  We believe that CRISPR is futuristic technology that can also be configured for detection of multiple other pathogens in the future.

DG-CSIR, Dr Shekhar C Mande commented that “CSIR labs such as CSIR-IGIB have been working on deep science and developing cutting edge technology and I am happy to see that leading Industry TATA Group is partnering towards its deployment. The strong partnership with industry in tackling COVID-19 has been the hallmark of CSIRs strategy in mitigation of COVID-19.  

Dr Anurag Agrawal, Director-IGIB highlighted that the technology was conceived and developed at CSIR IGIB under sickle cell mission and utilizes an indigenously developed cutting edge CRISPR Cas9 technology to specifically recognize COVID-19 sequence in a sample. A combination of CRISPR biology and paper-strip chemistry leads to a visible signal readout on a paper strip that can be rapidly assessed for establishing the presence of viral infection in a sample.